Dr. Curran studies various health issues, particularly in the fields of oncology, organ transplantation, and mental health. His research on blood cancers, especially chronic lymphocytic leukemia and acute myeloid leukemia, explores genetic mutations and their impacts on cancer development and treatment options. He also examines the allocation challenges in organ transplantation, highlighting the need for better strategies to utilize available organs effectively. Additionally, he investigates mental health conditions like obsessive-compulsive disorder and autism spectrum disorders to improve diagnosis and treatment, as well as maternal health issues like preterm labor complications.
Key findings
In a study on chronic lymphocytic leukemia, a mutation in the ribosomal protein RPS15 led to B-cell leukemia development in 37% of older mice, revealing potential treatment targets.
A 30-day halt of a quick placement system for difficult-to-transplant kidneys resulted in an increase in nonuse from 29.1% to 43.2%, indicating the inefficiencies in organ allocation.
Patients with obsessive-compulsive disorder showed increased impulsivity in attention-focused tasks, with a strong effect size of 0.83, clarifying specific impulsive behaviors related to OCD.
Among 1,041 patients with minor ischemic strokes, 10.4% experienced ongoing visual deficits, which were linked to higher death rates but did not impact overall functional recovery after 90 days.
The systematic review of hypertension management showed that these interventions can delay dementia onset, making them a cost-effective public health strategy.
Frequently asked questions
Does Dr. Curran study cancer?
Yes, he researches blood cancers, particularly focusing on chronic lymphocytic leukemia and acute myeloid leukemia.
What treatments has Dr. Curran researched?
He has explored various treatments related to blood cancers, organ transplantation strategies, and mental health conditions.
Is Dr. Curran's work relevant to kidney transplant patients?
Absolutely, his research on organ allocation strategies aims to improve kidney transplant outcomes for patients.
What does Dr. Curran study regarding women's health?
He studies complications during pregnancy, particularly preterm premature rupture of membranes and its implications for mothers and babies.
How does Dr. Curran's research benefit mental health patients?
His work aims to improve the diagnosis and treatment of disorders like obsessive-compulsive disorder and autism spectrum disorder.
Publications in plain English
Impulsivity in obsessive-compulsive disorder: A systematic review and meta-analysis.
2026
Journal of affective disorders
Abramovitch A, Borrelli DF, Curran C, Dar R
Plain English This study examined how impulsivity relates to obsessive-compulsive disorder (OCD) by comparing 27 previous studies involving 1,547 participants. The findings revealed that people with OCD show significantly higher impulsivity when focusing on attention (with a strong effect size of 0.83) but not much more impulsivity in terms of motor actions (very small effect size of 0.17). Understanding these differences is important because it clarifies that OCD itself does not make people more impulsive overall; rather, they may have specific types of impulsive behavior that need to be addressed.
Who this helps: This helps patients with OCD and their doctors find better ways to understand and treat the disorder.
There is nothing equitable about a wasted organ; eliminating out-of-sequence allocation for 30 days decreases utilization of hard-to-place kidneys.
2026
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Curran C, Wojtowicz J, Rodrigue JR, Delmonico F, Glazier A
Plain English This study looked at the effects of stopping a system that allows for quick placement of hard-to-place kidneys from deceased donors. Over 30 days, kidney nonuse increased significantly from 29.1% to 43.2%, meaning more kidneys went unused than before, especially those that are more challenging to transplant. The findings show that stopping this rescue system resulted in wasted resources and highlight the importance of having clear strategies for kidney allocation.
Who this helps: This helps patients in need of kidney transplants.
Mutant ribosomal protein RPS15 drives B cell malignancy through oxidative stress and genomic instability.
2026
Nature communications
Gutierrez C, Kwok M, Ruthen N, Waddicor P, Curran C +39 more
Plain English This study focused on a specific mutation in a ribosomal protein called RPS15, which is linked to a type of blood cancer known as chronic lymphocytic leukemia. The researchers found that this mutation causes initial harm to cell growth by creating stress on the cells and damaging their DNA, but in some cases, such as in certain aged mice, it leads to the development of B-cell leukemia with a risk of 37%. This matters because it shows how certain cancer mutations can bypass the body's protective mechanisms, leading to cancer progression.
Who this helps: This research helps patients with blood cancers and their doctors in understanding how mutations contribute to leukemia.
Training and Educational Pathways for Clinicians (Post-graduation) for the Assessment and Diagnosis of Autism Spectrum Disorders: A Scoping Review.
2025
Journal of autism and developmental disorders
Curran C, Roberts R, Gannoni A, Jeyaseelan D
Plain English This review looked at the training opportunities available for healthcare professionals after they graduate, specifically focusing on how they can learn to assess and diagnose Autism Spectrum Disorder (ASD). The study found that while post-graduate training can boost clinician confidence and improve services for diagnosing ASD, there is not enough evidence to show effective training pathways, which could make it harder for clinicians to provide help. Overall, improving training programs is crucial to ensure that clinicians have the skills needed to support people with ASD.
Who this helps: This benefits clinicians, patients with autism, and their families.
Preterm premature rupture of the membranes (PPROM): a study of patient experiences and support needs.
2025
Journal of reproductive and infant psychology
Challacombe FL, Suchomelova Z, Zampieri C, Hall M, Curran C +2 more
Plain English This study looked at the experiences of women and their families who had a condition called preterm premature rupture of membranes (PPROM), where the water breaks early in pregnancy. It found that out of 177 women surveyed, many felt they didn’t receive enough information or emotional support about their condition, which can lead to serious health problems for both mothers and babies. Improving care and support for these families is crucial because it can help reduce long-term psychological issues for everyone involved.
Who this helps: This helps patients and their families facing PPROM.
The epigenetic state of the cell of origin defines mechanisms of leukemogenesis.
2025
Leukemia
Li Z, Fierstein S, Tanaka-Yano M, Frenis K, Chen CC +12 more
Plain English This study looked at how the original type of blood cell affects the development and behavior of acute myeloid leukemia (AML). Researchers found that leukemia originating from hematopoietic stem cells (HSCs) has more aggressive features and a greater number of leukemic stem cells compared to leukemia from other blood cell precursors. Specifically, they discovered that certain inherited traits from normal HSCs are linked to this aggressive behavior, making HSC-AML harder to treat; they pinpointed a specific pathway that can be targeted for new therapies.
Who this helps: This benefits patients with acute myeloid leukemia and their doctors by suggesting new treatment options.
Quo vadis DSM-6? An expert survey on the classification, diagnosis, and differential diagnosis of body-focused repetitive behaviors.
2025
Comprehensive psychiatry
Moritz S, Hoyer LN, Sarna N, Abramovitch A, Curran C +2 more
Plain English This study looked at how experts classify body-focused repetitive behaviors (BFRBs), like hair pulling and skin picking. Researchers surveyed 50 professionals and found that over 60% agree on including specific behaviors in the BFRB category and believe these conditions should be classified as obsessive-compulsive disorders. The findings highlight the need for clearer guidelines in future mental health manuals to help differentiate BFRBs from other harmful behaviors, which is important for accurate diagnoses and treatments.
Who this helps: This benefits mental health professionals and patients struggling with BFRBs.
Health differences between rural and non-rural Texas counties based on 2023 County Health Rankings.
2025
BMC health services research
Ekren E, Maleki S, Curran C, Watkins C, Villagran MM
Plain English This study looked at health differences between rural and non-rural counties in Texas using 2023 County Health Rankings. It found that rural counties are more likely to be in the lowest groups for length of life and clinical care, meaning people there often live shorter lives and have less access to medical services. This is important because it highlights the need for targeted health programs to improve conditions for rural populations.
Who this helps: This helps rural patients and healthcare providers working to improve health services in their areas.
Digital Foetal Scalp Stimulation Versus Foetal Blood Sampling to Assess Foetal Well-Being in Labour: A Multicentre Randomised Controlled Trial.
2025
BJOG : an international journal of obstetrics and gynaecology
Yambasu S, Boland F, O'Donoghue K, Curran C, Shahabuddin Y +5 more
Plain English The study compared two methods of checking an unborn baby's health during labor: digital fetal scalp stimulation (dFSS) and fetal blood sampling (FBS). Among 43 women who participated, the rate of cesarean sections was 40% in the dFSS group and 47.8% in the FBS group, indicating that dFSS may lead to fewer cesarean deliveries. This research is important because it explores safer options for monitoring baby health during labor, potentially reducing surgical births without harming the mother or baby’s health.
Who this helps: This helps expectant mothers and their healthcare providers.
The impact of hypertension prevention and modification on dementia burden: A systematic review of economic studies.
2025
The journal of prevention of Alzheimer's disease
Lan M, John-Baptiste A, Curran C, Alemu FW, Avan A +2 more
Plain English This study looked at how preventing and controlling high blood pressure (hypertension) can reduce the impact of dementia, a serious brain disorder. After reviewing twelve studies, the researchers found that interventions to manage hypertension not only led to more people living longer but also delayed the onset of dementia. Overall, these interventions can be more cost-effective than doing nothing, making them an important consideration for healthcare systems.
Who this helps: This helps patients at risk for dementia and their healthcare providers.
Evaluation of Discrepant Infectious Disease Results in Deceased Organ Donors: Insights From a Retrospective Analysis of Post-Policy Testing.
2025
Transplant infectious disease : an official journal of the Transplantation Society
Dionne S, Akana H, Curran C, Van Slyck S
Plain English This study looked at blood test results from over 2,600 deceased organ donors to see how often initial test results for diseases like HIV and Hepatitis changed when a second sample was taken. They found that about 1.69% of the cases showed differences between the first and second tests, with 0.75% shifting from non-reactive to reactive results and 0.68% going the other way. Even though these discrepancies are rare, they matter because they can make it harder for doctors to make decisions about organ donations when there’s conflicting information.
Who this helps: This helps doctors and organ transplant teams make better decisions for potential organ donors.
Care of Women With Preterm Prelabour Rupture of the Membranes Prior to 24+0 Weeks of Gestation: Scientific Impact Paper No. 76.
2025
BJOG : an international journal of obstetrics and gynaecology
Hall M, Care A, Goodfellow L, Milan A, Curran C +7 more
Plain English This study focused on a condition called preterm prelabour rupture of the membranes (PPROM), which occurs when a pregnant woman's water breaks before 24 weeks of gestation. It found that while most babies born before 22 weeks do not survive, those born between 22 and 26 weeks have a higher risk of severe health issues and lower survival rates. The clear takeaway is that there is a need for more consistent information and care practices for both mothers and babies in this challenging situation.
Who this helps: This helps pregnant women and their families facing PPROM, as well as the doctors and midwives caring for them.
Persistent visual deficits in minor ischemic stroke.
2025
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
Qureshi H, Saraiya RG, Koneru M, Bhatti KS, Khullar M +9 more
Plain English This study looked at minor ischemic stroke (MIS) patients to see how persistent visual deficits affect their long-term recovery. Out of 1,041 MIS patients, 108 (10.4%) had ongoing visual issues, and these patients showed higher initial stroke severity and a higher death rate after 90 days (14.3% compared to 7.8% for those without visual deficits). The findings highlight that while visual deficits are linked to initial stroke severity, they do not seem to impact overall functional recovery after 90 days, suggesting a need for better ways to assess recovery in these patients.
Who this helps: This information helps doctors understand the implications of visual deficits in stroke patients and improve patient monitoring and treatment strategies.
Post-COVID-19-Associated Asymptomatic Sarcoidosis with Hypercalcemia and Renal Dysfunction: A Case Report and Literature Review.
2025
The American journal of case reports
Thiriveedi M, Patel H, Curran C, Patel S, Baddam S +2 more
Plain English This study looks at a 60-year-old woman who developed a rare condition called sarcoidosis after recovering from COVID-19. She had high calcium levels and kidney issues but did not show typical symptoms usually seen in sarcoidosis. Treatment with prednisone improved her condition, highlighting the need for doctors to be aware of unusual presentations of sarcoidosis after COVID-19.
Who this helps: This helps patients recovering from COVID-19 and doctors diagnosing complex health issues.
Emergency Medicine Residents' Perceptions of Geriatric Emergency Medicine and Careers: A Qualitative Study.
2025
The western journal of emergency medicine
Selman K, Jones AE, Curran C, Cameron-Comasco L, Coates WC +4 more
Plain English This study looked at how emergency medicine residents view geriatric emergency medicine (GEM) and their interest in pursuing a career in this field. It found that while participants recognized the importance of caring for older adults and believed specialized training would improve patient care, most of the 17 trainees did not want to pursue GEM careers. They cited concerns about working mainly with older patients, the complexity of geriatric cases, and unclear career paths as reasons for their lack of interest.
Who this helps: This research helps medical educators and program leaders understand how to better prepare future doctors to care for elderly patients.
Preterm prelabour rupture of membranes before 23 weeks' gestation: prospective observational study.
2024
BMJ medicine
Goodfellow L, Care A, Curran C, Roberts D, Turner MA +2 more
Plain English This study looked at the effects of early rupture of membranes before 23 weeks of pregnancy on both mothers and their babies. Among 326 women with this condition, 44% of babies were born alive, but only 26% survived until leaving the hospital, and 18% were healthy without serious health problems. A serious risk was identified for mothers, with 12% experiencing infections, and some requiring extreme medical care, including two deaths.
Who this helps: This research benefits families facing early pregnancy complications and healthcare providers supporting them.
Cardiac resynchronization therapy for patients with mild to moderately reduced ejection fraction and left bundle branch block.
2024
Heart rhythm
Cha YM, Lee HC, Mulpuru SK, Deshmukh AJ, Friedman PA +12 more
Plain English This study looked at how cardiac resynchronization therapy (CRT) affects patients with mild to moderately reduced heart function and a specific heart rhythm problem (left bundle branch block). The researchers found that after six months of receiving CRT, the heart's pumping efficiency (measured by ejection fraction) improved significantly from an average of 41.3% to 46.0%, and the size of the heart's left ventricle decreased from 116.1 mL to 87.6 mL (a reduction of nearly 25%). This is important because it shows that starting CRT earlier can lead to meaningful improvements in heart function for these patients.
Who this helps: Patients with heart failure and left bundle branch block.
Safeguarding adults at risk of abuse: identifying educational gaps amongst hospital staff to guide training.
2023
Irish journal of medical science
Killeen E, Higgins M, Keogh C, Russell S, Curran C
Plain English This study looked at how well hospital staff in Ireland understand and are prepared to protect vulnerable adults from abuse. Out of 223 staff members surveyed, many showed a poor understanding of the updated safeguarding policies, with significant gaps in their knowledge and confidence to report concerns. By pinpointing these educational shortcomings, hospitals can improve their training programs to better protect at-risk adults.
Who this helps: This helps patients who are at risk of abuse.
A Descriptive Analysis of Patient Outcomes and Experiences at a Student-Run Athletic Training Clinic.
2023
Journal of athletic training
Curran C, Baker JG, Smitley M, Baker RT
Plain English This study looked at how patients treated at a student-run athletic training clinic experienced their care and whether they improved after receiving treatment. Out of 388 patients with various muscle and joint injuries, most reported significant improvements: pain levels dropped by about 39%, function improved by 39%, and quality of life increased by around 43%, all within an average of just 11 days. These findings highlight that such clinics can effectively support both patient health and satisfaction in a cost-effective way.
Who this helps: This benefits patients seeking affordable care for musculoskeletal injuries.
Hepatocellular Carcinoma Risk Scores Predict Patients Under Surveillance at Low Risk of Benefit and High Risk of Harm.
2023
Digestive diseases and sciences
Curran C, Priest M, Datta S, Forrest EH, Stanley AJ +1 more
Plain English This study looked at how effective different risk scores are in deciding which patients with cirrhosis should be screened for liver cancer (hepatocellular carcinoma or HCC). Out of 482 patients, only 22 (4.6%) developed HCC, with most cases caught early through screening. However, for patients classified as low risk, the screening did not provide any benefit and instead resulted in many false alarms, with an overall estimate suggesting that 241 screenings are needed to detect one early-stage cancer while 36 patients experience unnecessary worry from false positive results.
Who this helps: This information benefits patients with cirrhosis by highlighting the importance of tailored surveillance strategies to avoid unnecessary anxiety and procedures.
Ocrevus reduces TH40 cells, a biomarker of systemic inflammation, in relapsing multiple sclerosis (RMS) and in progressive multiple sclerosis (PMS).
2023
Journal of neuroimmunology
Curran C, Vaitaitis G, Waid D, Volmer T, Alverez E +1 more
Plain English This study looked at how the drug Ocrelizumab affects a type of immune cell called TH40 cells in patients with two forms of multiple sclerosis (MS), relapsing MS (RMS) and progressive MS (PMS). The researchers found that Ocrelizumab successfully reduced the number of these inflammatory cells to normal levels in patients with RMS, while in those with PMS, the TH40 cells remained high, indicating ongoing inflammation. This is important because reducing these cells could help manage inflammation and symptoms in people with MS.
Who this helps: This benefits patients with relapsing multiple sclerosis.
Googling preterm prelabour rupture of the membranes: A systematic review of patient information available on the internet.
2023
BJOG : an international journal of obstetrics and gynaecology
Hall M, Challacombe F, Curran C, Shennan A, Story L
Plain English Researchers looked at the quality of online information about preterm prelabor rupture of the membranes (PPROM), a condition affecting 3% of pregnancies. They found that 39 websites shared information on PPROM, but most were not credible or easy to read: none were written for someone with an 11-year reading level or lower, and only three websites offered high-quality information. This matters because expecting parents may read inaccurate or confusing information online, which can lead to misunderstanding their health risks.
Who this helps: This helps patients and their families seeking reliable health information.
Refractory bradycardia and hypotension in patients with autonomic dysfunction treated with pseudoephedrine.
2023
BMJ case reports
Curran C, Davoudi F, Foster G, Gordan P
Plain English This study focused on a man in his 40s who was suffering from dangerously low heart rates and blood pressure due to a medical condition related to nerve function. Researchers found that adding pseudoephedrine to his treatment helped stabilize his heart rate and blood pressure, allowing him to stop using intravenous medications within 24 hours. This is important because it shows a new way to manage severe symptoms in patients with similar autonomic dysfunction.
Who this helps: This helps patients with autonomic dysfunction who experience severe bradycardia and hypotension.
The spectrum of COVID-19-associated chorioretinal vasculopathy.
2023
American journal of ophthalmology case reports
Carletti P, Shah A, Bair C, Curran C, Mai A +7 more
Plain English This study focused on five patients who experienced sudden vision loss linked to COVID-19. The research found that these patients, aged 16 to 44, had varying outcomes: some recovered their vision completely, while others faced permanent vision loss and required long-term treatment. This is important because it highlights that COVID-19 can damage the eyes, emphasizing the need for doctors to monitor and treat these patients quickly to preserve their sight.
Who this helps: This helps patients who have had COVID-19 and are experiencing vision problems, as well as their doctors.
Grifferty G, Shirley H, O'Brien K, Hirsch JL, Orriols AM +12 more
Plain English This study looked at research on leishmaniasis, a group of diseases spread by sandfly bites, in Kenya. Out of nearly 7,500 articles, only 269 were relevant; most focused on visceral leishmaniasis (VL) but only 1% on mucocutaneous leishmaniasis (MCL) and 2% on post-kala-azar dermal leishmaniasis (PKDL). The research gaps highlight a critical need for updated studies on prevention and policies to address these diseases affecting over 1.6 billion people globally.
Who this helps: This information benefits researchers and healthcare providers working on neglected tropical diseases.
Liver fibrosis markers and all cause mortality in people with type 2 diabetes: A population based study (The Ayrshire Diabetes Outcomes Cohort (ADOC) Study).
2023
Diabetes, obesity & metabolism
Collier A, Curran C, Cameron L, Wild SH, Byrne CD
Plain English This study looked at specific liver health markers in over 12,000 people with type 2 diabetes to see how they relate to overall death rates. Researchers found that 31% of participants died over nearly ten years, and those with high liver fibrosis scores had a significantly higher risk of death—up to 3.92 times more likely for one of the risk scores compared to those with low scores. This information is important because it shows the need for better care and preventive measures for people with type 2 diabetes who are at high risk for liver issues.
Who this helps: Patients with type 2 diabetes at risk for liver problems.
Clinical and Anatomic Outcomes of 3-Piece Poly(methyl methacrylate) Intraocular Lens Rescue and Needle-Assisted Transconjunctival Intrascleral Lens Fixation.
2023
Journal of vitreoretinal diseases
Curran C, Adam MK
Plain English This study looked at a new method for fixing dislocated eye lenses in patients who had previous eye surgery. Researchers found that out of 25 eyes treated, 24 successfully had their lenses reattached without stitches, leading to a significant improvement in vision from an average of 20/400 to about 20/30. The results show that this technique is effective and safe, making it a valuable option for restoring vision in patients with lens problems.
Who this helps: Patients who have had dislocated eye lenses.
How effective is public health policy in Scotland on vitamin D deficiency during pregnancy?
2023
Public health nutrition
Campbell R, Curran C, Hayward J, Godwin J, Johnston S +2 more
Plain English This study looked at how effective Scotland's public health policy is in providing vitamin D supplements to pregnant women and whether it helps prevent vitamin D deficiency. Out of 612 women, about 66% took the supplements as recommended, which did raise their vitamin D levels, but by the end of pregnancy, 33% of women in summer and 15% in winter still had low levels of vitamin D. This matters because even with the supplements, not all women achieved the necessary vitamin D levels, which could affect their health and that of their babies.
Who this helps: This helps pregnant women and their babies.
Outcomes of metastatic urothelial carcinoma following discontinuation of enfortumab-vedotin.
2022
Clinical genitourinary cancer
Curran C, Adib E, Kazakova V, Grivas P, Diamantopoulos LN +9 more
Plain English This study focused on what happens to patients with metastatic urothelial carcinoma after they stop taking enfortumab vedotin (EV), a treatment they received after trying other therapies. The researchers found that, out of 63 patients, those who received further treatment after stopping EV lived longer (an average of 43 weeks) compared to those who didn’t get more treatment (16.9 weeks). This information is important because it highlights the poor outcomes for these patients and suggests that the length of time they were on EV might influence their prognosis and treatment options afterward.
Who this helps: This benefits patients with metastatic urothelial carcinoma and their doctors by providing insights into treatment decisions after EV.
Genomic Features of Muscle-invasive Bladder Cancer Arising After Prostate Radiotherapy.
2022
European urology
Mossanen M, Carvalho FLF, Muralidhar V, Preston MA, Reardon B +9 more
Plain English This study looked at the genetic features of muscle-invasive bladder cancer (MIBC) that develops in patients after they receive radiation treatment for prostate cancer. Researchers analyzed tumor samples from 19 patients and found that, on average, it took about 12 years after prostate radiation for bladder cancer to develop. They discovered that while the overall genetic changes in these tumors were similar to those without prior radiation, the tumors from patients who underwent radiation had more short mutations likely caused by the previous treatment.
Who this helps: This research benefits doctors treating bladder cancer in patients with a history of prostate cancer, allowing for better understanding and management of these complex cases.
FGFR2/3 genomic alterations and response to Enfortumab Vedotin in metastatic urothelial carcinoma.
2022
BJUI compass
Adib E, El Zarif T, Jain RK, Skelton WP, Freeman D +8 more
Plain English This study looked at how patients with advanced bladder cancer (metastatic urothelial carcinoma) respond to a treatment called Enfortumab Vedotin (EV), focusing on those with specific genetic changes. It found that these genetic alterations did not significantly affect the treatment outcomes—meaning patients had similar chances of survival and tumor response regardless of their genetic makeup. This is important because it suggests that EV can be a viable treatment option for many patients, even if they have these genetic changes.
Who this helps: This helps patients with metastatic urothelial carcinoma and their doctors in choosing effective treatment options.
Longitudinal Evaluation of Circulating Tumor DNA Using Sensitive Amplicon-Based Next-Generation Sequencing to Identify Resistance Mechanisms to Immune Checkpoint Inhibitors for Advanced Urothelial Carcinoma.
2022
The oncologist
Ravi P, Ravi A, Riaz IB, Freeman D, Curran C +8 more
Plain English This study looked at how analyzing circulating tumor DNA (ctDNA) can help understand why some patients with advanced urothelial cancer don’t respond to immune checkpoint inhibitors (ICIs). Researchers tested 39 patients on ICIs and found that 95% showed genetic changes before treatment, and 100% had changes afterward. Notably, 7 out of 9 patients who responded to treatment had a drop in genetic changes, while 17 out of 20 patients who didn’t respond showed new genetic changes that were rarely seen in those receiving other chemotherapy. This is important because it shows ctDNA analysis can provide valuable information about how well treatments are working and identify ongoing resistance, allowing for better treatment strategies.
Who this helps: This helps patients with advanced urothelial cancer and their doctors in managing treatment.
Impact of renin-angiotensin system inhibitors on outcomes in patients with metastatic renal cell carcinoma treated with immune-checkpoint inhibitors.
2022
Clinical genitourinary cancer
Nuzzo PV, Adib E, Weise N, Curran C, Stewart T +9 more
Plain English This study looked at how renin-angiotensin system inhibitors (RASi) affect people with advanced kidney cancer (metastatic renal cell carcinoma) who are receiving immune therapies. The researchers found that patients taking RASi alongside their immune treatment had better overall survival, with a 65% lower risk of death compared to those not taking RASi. In one group, RASi users lived longer, and in another group, it improved how long patients could stay on treatment before it stopped working.
Who this helps: This research helps patients with metastatic kidney cancer and their doctors in choosing treatment options.
Interobserver agreement for the Chest Wall Injury Society taxonomy of rib fractures using computed tomography images.
2022
The journal of trauma and acute care surgery
Van Wijck SFM, Curran C, Sauaia A, Van Lieshout EMM, Whitbeck SS +3 more
Plain English This study tested a new naming system for rib fractures, proposed by the Chest Wall Injury Society, to see how well different doctors agree on classifying these injuries using CT scans. Out of 90 participating observers, there was strong agreement on where the fractures were located (85% agreement), moderate agreement on what type of fracture it was (46% agreement), and fair agreement on whether the fractures were displaced (38% agreement). Improving how doctors classify rib fractures is important because clear communication can lead to better treatment and care for patients.
Who this helps: Patients with rib fractures and their doctors.
Outcomes of a High-Volume Organ Procurement Organization in the Era of Increasing Donation After Circulatory Death.
2022
Progress in transplantation (Aliso Viejo, Calif.)
Hobeika MJ, Menser T, Myer K, Lopez A, Shaikh AF +5 more
Plain English This study looked at how organs are procured from donors who have died after their heart stopped beating, a process known as donation after circulatory death (DCD). In 2018, there were 2,466 organ donation referrals, with 1,890 being from DCD donors. The research found that 23% of family members did not approve of donating despite proper authorization, and certain factors like earlier use of heparin (a blood thinner) improved the chances of using these organs for transplantation. These findings help to improve policies and practices around organ donation, making it easier to use DCD organs effectively.
Who this helps: This helps patients in need of organ transplants.
Incidence of Germline Variants in Familial Bladder Cancer and Among Patients With Cancer Predisposition Syndromes.
2022
Clinical genitourinary cancer
Mossanen M, Nassar AH, Stokes SM, Martinez-Chanza N, Kumar V +11 more
Plain English This study looked at the occurrence of inherited genetic changes in people with bladder cancer, focusing on those who have a family history of the disease. Among 885 bladder cancer patients, 4.3% had a first-degree relative with the condition, while 34% of 80 patients suspected of having a hereditary cancer syndrome carried significant genetic variants. These findings are important because they highlight the potential role of genetic factors in bladder cancer and suggest that family history could help identify patients at greater risk for both bladder and related cancers.
Who this helps: This helps patients and doctors understand genetic risks associated with bladder cancer and informs decisions about testing and treatment.
Adverse drug reactions in an ageing PopulaTion (ADAPT) study: Prevalence and risk factors associated with adverse drug reaction-related hospital admissions in older patients.
2022
Frontiers in pharmacology
Cahir C, Curran C, Walsh C, Hickey A, Brannigan R +3 more
Plain English Researchers studied older patients (65 years and up) in Ireland to find out how often they were admitted to the hospital due to adverse drug reactions (ADRs), which are harmful effects from medications. They found that 10% of hospital admissions were related to ADRs, and among those cases, about 71% were potentially preventable. This is important because it highlights a need for better ways to identify and prevent these harmful reactions, which can make hospital stays longer and more complicated for older adults.
Who this helps: This research benefits older patients and their doctors by improving medication safety.
Maximizing donors' gifts: A comparison of actual and expected solid organ yield among VCA donors.
2021
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Vece GR, Robinson A, Rosendale J, Cherikh W, Curran C +4 more
Plain English This study looked at how many solid organs (like livers and kidneys) are donated by people who also give Vascularized Composite Allografts (VCA), which are complex transplants that include tissues like limbs or faces. Researchers found that almost all livers (94.1%) and kidneys (90.2%) from VCA donors were successfully transplanted, and the overall rate of organs donated was slightly higher than expected at 1.10 times the predicted amount. This matters because it shows that donating VCA does not interfere with the donation of vital organs, which can help save more lives.
Who this helps: This helps patients waiting for organ transplants.
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.
2021
Annals of oncology : official journal of the European Society for Medical Oncology
Grivas P, Khaki AR, Wise-Draper TM, French B, Hennessy C +123 more
Plain English This study looked at nearly 5,000 cancer patients who tested positive for COVID-19 to understand why some had more severe cases than others. They found that factors like older age, being male, obesity, and recent cancer treatments increased the chances of severe illness or death; specifically, 58% of the patients were hospitalized, and 14% died within 30 days. Understanding these connections is crucial as it can help doctors make better treatment decisions for cancer patients during pandemics.
Who this helps: This helps cancer patients and their doctors.
Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration.
2021
BJU international
Ravi P, Pond GR, Diamantopoulos LN, Su C, Alva A +17 more
Plain English Researchers studied the effectiveness of different chemotherapy treatments for patients with muscle-invasive bladder cancer who had surgery afterward. They found that 58.1% of the 625 patients achieved a near-complete response (pathological stage ypT0 or ypTis), showing a low 5-year recurrence rate of 9%. Conversely, those with less favorable stages (ypTa and ypT1) had higher recurrence risks of 16% and 30%, indicating that identifying the right treatment response is crucial for choosing further treatment options.
Who this helps: This information benefits patients with bladder cancer and their doctors in making informed treatment decisions.
Clinical Outcomes of Platinum-ineligible Patients with Advanced Urothelial Carcinoma Treated With First-line PD1/L1 Inhibitors.
2021
Clinical genitourinary cancer
Pond GR, Agarwal A, Ornstein M, Garcia J, Gupta R +11 more
Plain English This study looked at how effective first-line PD1/L1 inhibitors (a type of cancer treatment) are for patients with advanced urothelial carcinoma who cannot receive platinum-based chemotherapy. Out of 79 patients, the treatment led to a response rate of about 28%, and the average survival time was 45 weeks. While the effectiveness was similar to earlier trials, more patients experienced severe side effects.
Who this helps: This benefits patients with advanced urothelial carcinoma who cannot use standard platinum chemotherapy.
Angiotensin Blockade Modulates the Activity of PD1/L1 Inhibitors in Metastatic Urothelial Carcinoma.
2021
Clinical genitourinary cancer
Jain RK, Skelton Iv WP, Pond GR, Naqvi M, Kim Y +7 more
Plain English This study looked at how certain blood pressure medications, called ACE inhibitors and ARBs, affect the effectiveness of cancer treatments known as PD1/L1 inhibitors in patients with metastatic urothelial carcinoma (mUC). Researchers found that patients taking these medications alongside PD1/L1 inhibitors had a higher chance of their tumors shrinking—about 2.7 times more likely based on the initial data set. This is important because improving treatment responses can lead to better outcomes for patients facing this aggressive form of cancer.
Who this helps: This benefits patients with metastatic urothelial carcinoma.
An economic analysis comparing health care resource use and cost of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin versus gemcitabine and cisplatin as neoadjuvant therapy for muscle invasive bladder cancer.
2021
Urologic oncology
Montazeri K, Dranitsaris G, Thomas JD, Curran C, Preston MA +7 more
Plain English This study looked at the use of two different chemotherapy treatments for patients with muscle-invasive bladder cancer: one using a combination called ddMVAC and the other called GC. The researchers found that patients receiving GC had significantly lower costs—around 41% less, or about $7,410 on average—compared to those receiving ddMVAC, even though both treatments delivered similar amounts of the key drug, cisplatin. This matters because choosing the more cost-effective treatment can help healthcare systems save money while still providing effective care to patients.
Who this helps: This helps patients and healthcare providers by promoting more affordable treatment options.
The association between deprivation and the incidence and survival of patients with hepatocellular carcinoma in the West of Scotland.
2021
Expert review of gastroenterology & hepatology
Curran C, Stanley AJ, Barclay ST, Priest M, Graham J
Plain English This study looked at how living in poorer areas affects the number of people diagnosed with liver cancer (hepatocellular carcinoma or HCC) and their survival rates in the West of Scotland. Researchers found that people in the most deprived areas had nearly double the rate of new HCC cases compared to those in the least deprived areas (8.4 vs. 4.3 per 100,000), but there was no difference in how long patients lived after their diagnosis, with survival rates around 368 days for the most deprived and 325 days for the least deprived. This matters because it highlights that while socioeconomic status affects how many people get liver cancer, it does not seem to impact their survival after diagnosis.
Who this helps: This helps patients and healthcare providers understand the impact of social factors on liver cancer diagnoses.
Plain English This research looked at how long kidneys take to get from the donor to the transplant center and how that time relates to the time the kidneys are kept cold before surgery. The study found that longer transit times were linked to an increase in cold ischemic time, with each hour of transit adding about 30 minutes to the cold storage period. This matters because longer cold ischemic times can harm kidney function after transplantation, affecting patient outcomes.
Who this helps: This helps patients receiving kidney transplants.
Correction to: Diagnostic yield of a custom-designed multi-gene cancer panel in Irish patients with breast cancer.
2020
Irish journal of medical science
McVeigh ÚM, McVeigh TP, Curran C, Miller N, Morris DW +1 more
Plain English This paper corrects previous errors in the figures of a study that looked at a multi-gene test for diagnosing breast cancer in Irish patients. The researchers aimed to determine how effectively this test could identify important genetic changes related to breast cancer. This is important because having accurate genetic information can help doctors make better treatment decisions for patients.
Who this helps: This helps patients with breast cancer and their doctors.
Conditional immune toxicity rate in patients with metastatic renal and urothelial cancer treated with immune checkpoint inhibitors.
2020
Journal for immunotherapy of cancer
Nuzzo PV, Pond GR, Abou Alaiwi S, Nassar AH, Flippot R +7 more
Plain English This study looked at how often patients with advanced kidney and bladder cancer develop immune-related side effects after being treated with immune checkpoint inhibitors (ICIs). Out of 470 patients, 186 (about 40%) experienced at least one side effect, with the most common being low thyroid function and skin rashes. The researchers found that while side effects tended to decrease over time, some patients (15.6%) started showing symptoms more than a year after beginning treatment, highlighting the need for ongoing monitoring even after therapy ends.
Who this helps: This benefits patients receiving cancer immunotherapy, as well as their doctors in managing potential side effects.
Guru Sonpavde Dory Freeman Amin H Nassar Pier Vitale Nuzzo Bradley A McGregor Rohit K Jain Matthew Mossanen Toni K Choueiri Elio Adib Sarah Abou Alaiwi
Physician data sourced from the
NPPES NPI Registry
.
Publication data from
PubMed
.
Plain-English summaries generated by AI.
Not medical advice.